Ezetimibe added to on-going statin therapy for treatment of primary hypercholesterolemia: efficacy and safety in patients with Type 2 diabetes mellitus

被引：0
|
作者：
Simons, L
Musliner, T
Quinto, K
Cho, M
Gumbiner, B
机构：
[1] Merck Schering Plough Pharmaceut, N Wales, PA USA
[2] Univ New S Wales, St Vincents Hosp, Lipid Dept, Sydney, NSW, Australia
来源：
DIABETOLOGIA | 2002年 / 45卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1209
引用
收藏
页码：A389 / A389
页数：1
相关论文
共 50 条
  • [31] Comparison of the Efficacy of Ezetimibe Combination Therapy and High-Intensity Statin Monotherapy in Type 2 Diabetes
    Park, So Young
    Jun, Ji Eun
    Jeong, In-Kyung
    Ahn, Kyu Jeung
    Chung, Ho Yeon
    Hwang, You-Cheol
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2024, 109 (07): : 1883 - 1890
  • [32] Efficacy and safety of sitagliptin when added to ongoing metformin therapy in patients with type 2 diabetes
    Scott, R.
    Loeys, T.
    Davies, M. J.
    Engel, S. S.
    DIABETES OBESITY & METABOLISM, 2008, 10 (10): : 959 - 969
  • [33] Efficacy and safety of glimepiride as initial treatment in Chinese patients with Type 2 diabetes mellitus
    Guo, Xiao-hui
    Lv, Xiao-feng
    Han, Ping
    Zhang, Xiu-zhen
    Yang, Hua-zhang
    Duan, Wen-ruo
    Gao, Yan
    CURRENT MEDICAL RESEARCH AND OPINION, 2013, 29 (03) : 169 - 174
  • [34] Efficacy and safety of glimepiride as initial treatment in Russian patients with type 2 diabetes mellitus
    Ametov, A. S.
    Abaeva, F. A.
    DIABETES MELLITUS, 2013, 16 (04): : 95 - 100
  • [35] The efficacy and safety of acarbose in the treatment of type 2 diabetes mellitus in elderly patients.
    Chiasson, JL
    Josse, RG
    Dorman, JM
    Gerstein, HC
    Lau, D
    Leiter, LA
    Maheux, P
    Meneilly, GS
    Murphy, L
    Rodger, NW
    Ross, SA
    Ryan, E
    Yale, JF
    Wolever, TMS
    Haller, T
    Elias, I
    DIABETOLOGIA, 1999, 42 : A223 - A223
  • [36] Comparison of Efficacy and Safety of Statin–Ezetimibe Combination Therapy with Statin Monotherapy in Patients with Diabetes: A Meta-Analysis of Randomized Controlled Studies
    Kwang-Hee Shin
    Hye Duck Choi
    American Journal of Cardiovascular Drugs, 2022, 22 : 395 - 406
  • [37] LDL-C goal attainment with the addition of ezetimibe to on-going simvastatin treatment in coronary heart disease patients with hypercholesterolemia
    Brohet, C
    Banai, S
    Alings, AMW
    Massaad, R
    Davies, MJ
    Allen, C
    CURRENT MEDICAL RESEARCH AND OPINION, 2005, 21 (04) : 571 - 578
  • [38] Early efficacy and safety of statin therapy in Korean patients with hypercholesterolemia: Daegu and Gyeongbuk Statin Registry
    Bae, Han Joon
    Cho, Yun-Kyeong
    Park, Hyoung-Seob
    Yoon, Hyuck-Jun
    Kim, Hyungseop
    Han, Seongwook
    Hur, Seung-Ho
    Kim, Yoon-Nyun
    Kim, Kwon-Bae
    Ryu, Jae-Kean
    Nah, Deug Young
    Nam, Chang-Wook
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2020, 35 (02): : 342 - 350
  • [39] A comparative meta-analysis of the efficacy of statin-ezetimibe co-therapy versus statin monotherapy in reducing cardiovascular and cerebrovascular adverse events in patients with type 2 diabetes mellitus
    Miao, X-Y
    Liu, H-Z
    Jin, M-M
    Sun, B-R
    Tian, H.
    Li, J.
    Li, N.
    Yan, S-T
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2019, 23 (05) : 2302 - 2310
  • [40] The efficacy of the co-administration of ezetimibe with high dose statin therapy in heterozygous familial hypercholesterolemia patients
    Metalinos, G.
    Pitsavos, C.
    Skoumas, J.
    Papadimitriou, L.
    Masoura, C.
    Chrysohoou, C.
    Kambaxis, M.
    Papaioannou, T.
    Giotsas, N.
    Toutouza, M.
    Stefanadis, C.
    ATHEROSCLEROSIS SUPPLEMENTS, 2007, 8 (01) : 207 - 207
12345